Academician
MAHMUT EMRE YILDIRIM
Profesör
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 34 + YÖKSİS · co-author record: 18
h-index
11
Percentile in Türkiye: 77
#37 of 231 at their university by h-index
- i10-index
- 11
- Total citations
- 359 Top 20% in Türkiye
- Per article
- 6.9
- FWCI
- 1.11 1.00 = world average
- World top 1%
- 0
- World top 10%
- 7
Most cited articles
- Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection
- Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
- Comparison of second line treatment outcomes between sensitive and refractory small cell lung cancer patients a retrospective analysis
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 18 articles (81 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 4.
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 52
- With an akaturk profile
- 10
- Turkish institutions
- 7
- Co-authored works
- %34
Academic co-authors 10
- UMUT KEFELİ Profesör · Kocaeli Üniversitesi 13
- MAHMUT GÜMÜŞ Profesör · İstanbul Medeniyet Üniversitesi 12
- AHMET BİLİCİ Profesör · İstanbul Medipol Üniversitesi 9
- MESUT ŞEKER Profesör · İstanbul Medipol Üniversitesi 9
- TANER KORKMAZ Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 2
- ERDOĞAN SELÇUK ŞEBER Doçent · Tekirdağ Namık Kemal Üniversitesi 1
- HATİCE ODABAŞ Profesör · Sağlık Bilimleri Üniversitesi 1
- MERVE TURAN Doktor Öğretim Üyesi · Aydın Adnan Menderes Üniversitesi 1
- MUSTAFA ÖNCEL Profesör · İstanbul Medipol Üniversitesi 1
- NEDİM TURAN Profesör · Sağlık Bilimleri Üniversitesi 1
National collaboration 7 institutions
- Kocaeli Üniversitesi 13 works · 1 academics
- İstanbul Medeniyet Üniversitesi 12 works · 1 academics
- İstanbul Medipol Üniversitesi 9 works · 3 academics
- Acıbadem Mehmet Ali Aydınlar Üniversitesi 2 works · 1 academics
- Aydın Adnan Menderes Üniversitesi 1 works · 1 academics
- Sağlık Bilimleri Üniversitesi 1 works · 2 academics
- Tekirdağ Namık Kemal Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 42
BALA BAŞAK ÖVEN USTAALİOĞLU 8TAFLAN SALEPÇİ 7DİNÇER AYDIN 4NUR ŞENER 4BERKANT SÖNMEZ 3METİN KEMENT 3BALA BAŞAK USTAALİOĞLU 2BURÇAK ERKOL 2NURGÜL YAŞAR 2SİNEMİS YÜKSEL 2ALPER SONKAYAASLIHAN GÜVEN MERTASLIHAN MERTAYŞEGÜL ÜÇÜNCÜ KEFELİBAŞAK ÖVENBURÇAK ERKOL YILMAZBURÇAK YILMAZDENİZ TATAROĞLU ÖZYÜKSELERDERYA ÖZTAŞ GÜLERDİLEK YAVUZEREBRU SARIFATİH MUHAMMED AYDINFATİH YAVUZ ERKALGÜLİN ALKAN ŞENHEVES SÜRMELİHÜLYA GÖZÜMEHMET KARADUMANMURAT AYHANMUSTAFA CANHOROZNAGEHAN BARIŞIK ÖZDEMİRNESRİN CANPOLATPERRAN FULDEN YUMUKRAMAZAN YILDIZRECEP USTAALİOĞLUSERDAR TURHALSEVAL AY ERSOYÖZGE POLATÖZGÜR AÇIKGÖZÖZLEM BALVANÖZLEM BALVAN ERCELEP
Show all (42)
ÖZLEM ÇAKIR MADENCİİSMET TAMER
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Indexes and citation percentiles
?Top 1%0
Top 10%7
Avg · n 33
%60.5
Other counts
Scopus (SJR)
- YÖKSİS rows 9
WoS (JCR)
- YÖKSİS rows 10
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
11 journals
Narrow down
Article list
- 2026 Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma OpenAlex top 10% OpenAlex 95.8%
- 2026 Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide OpenAlex top 10% OpenAlex 90.3%
- 2026 Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk–Stratified Analysis OpenAlex top 10% OpenAlex 91.5%
- 2026 Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study OpenAlex 87.4%
- 2026 486P Machine learning–based prediction of nivolumab response using systemic inflammatory biomarkers in advanced NSCLC: A real-world study OpenAlex 21.0%
- 2026 Prognostic Impact of Immune-Related Adverse Events in Patients with Non–Small Cell Lung Cancer Treated with Second-Line Nivolumab: A Single-Center Real-World Experience OpenAlex 28.9%
- 2026 Pneumococcal Vaccination in Oncology Practice in Turkiye: Results of Patient and Physician Survey Studies OpenAlex 23.3%
- 2026 Impact of Post-chemotherapy Radiotherapy on Survival Outcomes in Inoperable Malignant Mesothelioma: A Single-center Retrospective Analysis OpenAlex 27.6%
- 2026 Pan‑immune‑inflammation value as a prognostic and predictive biomarker in metastatic non‑small cell lung cancer treated with nivolumab: A real‑world study OpenAlex 68.2%
- 2025 Impact of Metastasectomy on Survival Outcomes in Colorectal Cancer: A Single Center Retrospective Study OpenAlex 4.7%
- 2025 Tumor-infiltrating lymphocytes as predictive biomarkers in neoadjuvant treatment of HER2-positive breast cancer OpenAlex top 10% OpenAlex 92.5%
- 2025 Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study OpenAlex 87.9%
- 2025 Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage OpenAlex 75.2% unverified OpenAlex match
- 2025 Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab OpenAlex 69.8% unverified OpenAlex match
- 2025 Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer OpenAlex 63.5%
- 2025 Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine OpenAlex 73.8%
- 2025 Single-Center Real World Study of Everolimus and Exemestane in HR+/HER2− Metastatic Breast Cancer Following CDK4/6 Inhibitor Therapy OpenAlex 72.0%
- 2025 Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment OpenAlex 7.1%
- 2025 The Effect of Concomitant Metformin Use on Progression-Free and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab unverified OpenAlex match
- 2025 Effect of Family and Personal Medical History on Treatment Outcomes of Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC) OpenAlex 23.6%